Article
Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam.
European journal of gastroenterology & hepatology - 1 Nov 2012
Grady Bart P X, Vanhommerig Joost W, Schinkel Janke, Weegink Christine J, Bruisten Sylvia M, Lindenburg Catherina E A, Prins Maria
Abstract excerpt
BACKGROUND: More than two-thirds of hepatitis C virus (HCV) infections are associated with injecting drug use. Despite the wide availability of standard treatment with pegylated interferon and ribavirin, active drug users (DU) have limited access to HCV treatment. Physicians may be reluctant to prescribe treatment because of the presumed high risk of reinfection. However, data on reinfection in treated DU remain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
